NEW YORK, April 9 - German genomics-tool start up Sloning Biotechnology today said it has partnered with neighboring liquid-handling company Hamilton Bonaduz to commercialize its Slonomat gene synthesis robot.
The collaboration means that Sloning's sloning technology, which allows for the "industrial synthesis" of DNA molecules, can be fully automated.
According to Sloning, sloning can help researchers produce "any gene or large DNA molecule ... within a couple of days." The Slonomat platform, meanwhile, has the capacity of several hundred genes per year. Sloning technology differs from traditional cloning in that it "works without the need for insert restriction sites," the company said. "It allows parallel synthesis of several gene variants and shows inherent error correction."
The privately held company, founded in December 2001, is based just outside Munich.